Press Release
Neuralia TMS Specialises in Pharmacogenetic Testing Across Australia
Australia, 24th Mar 2025, – Neuralia TMS, a leader in non-invasive therapeutic treatments, has announced the expansion of its services to include pharmacogenetic testing across Australia. This new offering enables the company to enhance its ability to tailor treatments to the specific needs of individual patients. The integration of pharmacogenetic testing into Neuralia TMS’s service portfolio further advances the company’s personalised approach to mental health and chronic pain management.
Pharmacogenetic testing involves analysing an individual’s genetic profile to assess how they may respond to specific medications. By combining this testing with existing therapies such as Transcranial Magnetic Stimulation (TMS) and Transcranial Direct Current Stimulation (tDCS), Neuralia TMS can offer more customised treatment plans for conditions such as depression, anxiety, PTSD, OCD, chronic pain, and Parkinson’s disease.
“By incorporating pharmacogenetic testing, Neuralia TMS can now offer therapies that are more precisely aligned with each individual’s genetic profile. This step allows for a more personalised and targeted approach to treatment,” said a spokesperson for Neuralia TMS. “It enables patients to receive care that is more effective while minimising potential side effects associated with less tailored treatments.”
Neuralia TMS is known for its non-invasive, drug-free therapies, which provide an alternative to traditional medication-based treatments. TMS, a therapy that uses magnetic pulses to stimulate areas of the brain involved in mood regulation, has been recognised for its effectiveness in treating a variety of conditions. Similarly, tDCS offers a non-invasive method of neuromodulation, allowing patients to receive treatment from the comfort of their own homes.
The integration of pharmacogenetic testing into Neuralia TMS’s offerings strengthens its commitment to personalised medicine. The testing provides important insights into how patients may respond to certain medications, ensuring that treatments are tailored to each person’s genetic makeup. This approach can be particularly valuable for patients who have not responded well to standard treatments or have experienced adverse effects from medications.
“The combination of pharmacogenetic testing with existing therapies brings a more comprehensive approach to treatment. Understanding how a patient’s genetics influence their response to medications allows for the development of a more effective care plan, reducing the need for trial-and-error,” said the spokesperson for Neuralia TMS. “This ultimately improves patient outcomes and supports better long-term management of their conditions.”
Neuralia TMS’s pharmacogenetic testing services are available to patients across Australia. The company remains at the forefront of offering non-invasive therapies, and the addition of pharmacogenetic testing further establishes Neuralia TMS as a leader in the field of personalised medicine. The testing process is straightforward, requiring only a small sample of saliva or blood to identify key genetic markers that influence drug metabolism.
Looking to the future, Neuralia TMS is focused on expanding its services and incorporating the latest advancements in medical technology. “As the field of pharmacogenetics continues to evolve, new opportunities will emerge to refine treatments and improve outcomes. Neuralia TMS is dedicated to staying at the cutting edge of these developments, ensuring patients continue to receive the most individualised and effective care available,” the spokesperson added.
Neuralia TMS remains committed to enhancing patient care through personalised, non-invasive treatments that address a wide range of mental health and chronic conditions. By integrating the latest scientific advancements, the company continues to ensure that patients receive tailored, evidence-based care designed to deliver optimal results.
For more information about Neuralia TMS and its pharmacogenetic testing Australia services, please contact Neuralia TMS at 08 6230 3996 or via email at info@neuralia.com.au.
Media Contact
Organization: Neuralia TMS
Contact
Person: Dr Shanek Wick
Website:
https://www.neuraliatms.com.au/
Email:
info@neuralia.com.au
Contact Number: 61862303996
Country:Australia
The post Neuralia TMS Specialises in Pharmacogenetic Testing Across Australia appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
United States, 1st May 2025, – Actbest has established itself as an online supplier of high-quality e-bikes, committed to transforming eco-friendly commuting into a convenient experience that everyone can enjoy. As a trusted brand in the e-bike industry, Actbest combines a passion for sustainability with a strong commitment to customer satisfaction.
The company’s core philosophy revolves around quality assurance, ensuring that each product delivers exceptional performance while providing customers with excellent value. More than just a means of transportation, Actbest e-bikes are a catalyst for a healthy lifestyle, combining fitness with the joy of powered riding.
Riders First: Explore Product Line and What They’re Saying
Actbest stands out in the competitive e-bike market thanks to its customer-centric philosophy and rich product line. Actbest e-bikes have received rave reviews from many riders and are widely praised for their smooth and safe performance on a variety of terrains. This positive feedback is the result of Actbest’s commitment to enhancing the riding experience, actively listening to customer needs, and improving product design based on this feedback to truly create an ideal travel companion.
“Every ride with Actbest is a safe and enjoyable adventure, designed just for you,” said a company representative. This also reflects the brand’s determination to create ideal travel companions for diverse consumer needs. Whether it is commuter ebike, mountain ebike, fat tire ebike or folding ebike, all Actbest e-bikes put quality and safety first.
Designed, Manufactured, and Tested In-House
One of Actbest’s major competitive advantages is its vertically integrated production model. The company owns and operates its own dedicated factory, where it independently innovates, designs and manufactures high-quality e-bikes. This comprehensive self-production model allows it to have full control over the entire production process, from the initial design concept to the final assembly.
This manufacturing independence allows Actbest to maintain strict quality standards for performance, durability and safety across its entire product line. Actbest continues to push the boundaries of e-mobility innovation and is committed to providing a well-designed and enjoyable riding experience.
Join the Action: Create a Green Future Together
For consumers who pursue a more active and environmentally friendly future, Actbest provides more than just products; it also provides an enhanced lifestyle that combines technological innovation with ecological responsibility.
For more information about Actbest and its range of e-bikes, visit https://actbestbike.com.
Media Contact
Organization: ACTBEST
Contact
Person: Doralin
Website:
https://actbestbike.com/
Email:
doralin@actbest.net
Contact Number: 13396965949
Country:United States
The post Actbest – Revolutionizing Eco-Friendly Mobility with Innovative E-Bikes appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Cristobal Bull, Nowhere to Hide, The Islander, and What Mommy Doesn’t See Win April BREW Award
Australia, 1st May 2025, –
The Chrysalis BREW Project has announced the winners of the April 2025 BREW Readers’ Choice Award Book of the Month. The titles recognised this month are Cristobal Bull by Chris Corbett, Nowhere to Hide by Jude Austin, The Islander by David W. Berner, and What Mommy Doesn’t See by Karen Ledbetter.
Cristobal Bull by Chris Corbett was noted for its character construction and storytelling approach. The review from The Chrysalis BREW Project stated, “Corbett’s focus on the Bull’s past serves the story’s depth and flow well.” It also noted that the author “presents the Bull as a human being first, with motivations, history, and internal logic.”
Nowhere to Hide by Jude Austin was recognised for its exploration of interspecies dynamics and ethical complexity. The review highlighted, “The best parts of this book highlight what happens when two intelligent life forms attempt to understand each other without the option of walking away.”
David W. Berner’s The Islander was chosen for its portrayal of introspection and change. According to the review, the book is “not a travel story but a story of travelling inward, away from things, people, and situations, and toward clarity.”
Karen Ledbetter’s What Mommy Doesn’t See was recognised for its narrative focus and treatment of sensitive topics. The review noted that “Ledbetter handles sensitive scenes with a deliberate lack of over-dramatisation” and “presents the narrative from the child’s perspective without unnecessary exposition.”
More details about this announcement are on The Chrysalis BREW Project website.
About the Award
The BREW Readers’ Choice Award is a monthly and annual celebration of literature, where readers determine the most beloved books. Book of the Month winners automatically contend for the Reader’s Choice of the Year Awards, which highlight exceptional literary works. To nominate a book or learn more, visit the official page of the BREW Readers’ Choice Award.
Media Contact
Organization: The Chrysalis BREW Project
Contact
Person: The Chrysalis BREW Project
Website:
https://thechrysalisbrewproject.com
Email:
info@thechrysalisbrewproject.com
Country:Australia
The post Cristobal Bull, Nowhere to Hide, The Islander, and What Mommy Doesn’t See Win April BREW Award appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Cristobal Bull, Nowhere to Hide, The Islander, and What Mommy Doesn’t See Win April BREW Award
Australia, 1st May 2025, –
The Chrysalis BREW Project has announced the winners of the April 2025 BREW Readers’ Choice Award Book of the Month. The titles recognised this month are Cristobal Bull by Chris Corbett, Nowhere to Hide by Jude Austin, The Islander by David W. Berner, and What Mommy Doesn’t See by Karen Ledbetter.
Cristobal Bull by Chris Corbett was noted for its character construction and storytelling approach. The review from The Chrysalis BREW Project stated, “Corbett’s focus on the Bull’s past serves the story’s depth and flow well.” It also noted that the author “presents the Bull as a human being first, with motivations, history, and internal logic.”
Nowhere to Hide by Jude Austin was recognised for its exploration of interspecies dynamics and ethical complexity. The review highlighted, “The best parts of this book highlight what happens when two intelligent life forms attempt to understand each other without the option of walking away.”
David W. Berner’s The Islander was chosen for its portrayal of introspection and change. According to the review, the book is “not a travel story but a story of travelling inward, away from things, people, and situations, and toward clarity.”
Karen Ledbetter’s What Mommy Doesn’t See was recognised for its narrative focus and treatment of sensitive topics. The review noted that “Ledbetter handles sensitive scenes with a deliberate lack of over-dramatisation” and “presents the narrative from the child’s perspective without unnecessary exposition.”
More details about this announcement are on The Chrysalis BREW Project website.
About the Award
The BREW Readers’ Choice Award is a monthly and annual celebration of literature, where readers determine the most beloved books. Book of the Month winners automatically contend for the Reader’s Choice of the Year Awards, which highlight exceptional literary works. To nominate a book or learn more, visit the official page of the BREW Readers’ Choice Award.
Media Contact
Organization: The Chrysalis BREW Project
Contact
Person: The Chrysalis BREW Project
Website:
https://thechrysalisbrewproject.com
Email:
info@thechrysalisbrewproject.com
Country:Australia
The post Cristobal Bull, Nowhere to Hide, The Islander, and What Mommy Doesn’t See Win April BREW Award appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Cristobal Bull, Nowhere to Hide, The Islander, and What Mommy Doesn’t See Win April BREW Award
Actbest – Revolutionizing Eco-Friendly Mobility with Innovative E-Bikes
Cristobal Bull, Nowhere to Hide, The Islander, and What Mommy Doesn’t See Win April BREW Award
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
-
Press Release2 days ago
Safetyvalue Trading Center Launches Mobile App V2 With Biometric Login and Real-Time Alerts
-
Press Release7 days ago
The Illusion of Change — A Bold Philosophical Reflection by Adrian Gabriel Dumitru Challenges the True Nature of Transformation
-
Press Release1 week ago
Hybrid Collapse Releases Captivating New Album “Biopolitics”
-
Press Release7 days ago
Raven Keiara named Los Angeles finalist for 2025 August Wilson New Voices Monologue Competition
-
Press Release7 days ago
Champion Window Tinting Announces Cutting-Edge Solutions for Energy Savings and Privacy Enhancement
-
Press Release6 days ago
Cloom Tech Offers OEM Wire Harness Manufacturing Solutions
-
Press Release3 days ago
New Kindle Edition Book PERCEPTIONS Philosophical Essays About the Illusion of the Self’ Challenges Readers to Explore Life’s Meaning Through Contradictory Perspectives
-
Press Release1 week ago
LED Releases Captivating New Single “GANGSTALK”